Stock listing
NASDAQ:TSVT 2Seventy Bio Inc Stock
Follow 2Seventy Bio Inc into a list and get an email when it puts out news.
Last close · NASDAQ:TSVT
$5.00 USD
Close on May 22, 2025 · No longer trades
- Lowest – highest close
- $1.57 – $42.56 USDSince Nov 3, 2021 · lowest Nov 21, 2023 · highest Nov 9, 2021
Delisted NASDAQ:TSVT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:TSVT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
2Seventy Bio Inc on 6ix
- Calls
- 8 calls with a replay · 8 with a transcript · latest Nov 12, 2024
- Decks
- 11 decks · latest Nov 12, 2024
Events
| Call | When | Status |
|---|---|---|
| 2Seventy Bio (TSVT) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 8:00 AM ET | Replay |
| 2Seventy Bio (TSVT) Q2 2024 Earnings Call | Wed, Aug 07, 2024 · 8:00 AM ET | Replay |
| 2Seventy Bio (TSVT) Q1 2024 Earnings Call | Wed, May 08, 2024 · 8:00 AM ET | Replay |
| 2Seventy Bio (TSVT) Q4 2023 Earnings Call | Tue, Mar 05, 2024 · 8:00 AM ET | Replay |
| 2Seventy Bio (TSVT) Q3 2023 Earnings Call | Tue, Nov 14, 2023 · 8:00 AM ET | Replay |
| 2Seventy Bio (TSVT) Q2 2023 Earnings Call | Mon, Aug 14, 2023 · 8:00 AM ET | Replay |
| 2Seventy Bio (TSVT) Q1 2023 Earnings Call | Wed, May 03, 2023 · 4:30 PM ET | Replay |
| 2Seventy Bio (TSVT) Q2 2022 Earnings Call | Wed, Aug 10, 2022 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (November 2024) | Corporate update | 22 slides | Nov 12, 2024 |
| Investor Presentation (September 2024) | Investor deck | 22 slides | Sep 25, 2024 |
| Investor Presentation (June 2024) | Investor deck | 24 slides | Jun 11, 2024 |
| 2023 ASH Annual Meeting | Conference | 26 slides | Dec 12, 2023 |
| Investor Presentation (September 2023) | Investor deck | 34 slides | Sep 13, 2023 |
| Investor Presentation (June 2023) | Investor deck | 41 slides | Jun 14, 2023 |
| Technical Presentation (May 2023) | Technical | 64 slides | May 19, 2023 |
| Investor Presentation (March 2023) | Investor deck | 40 slides | Mar 7, 2023 |
| Investor Presentation (January 2023) | Investor deck | 35 slides | Jan 9, 2023 |
| Investor Presentation (August 2022) | Investor deck | 33 slides | Aug 10, 2022 |
All 11 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2022) | Investor deck | 30 slides | Jan 11, 2022 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eli Casdin Other companies: GeneDx Holdings Corp. (Board Member · Since at least Apr 27, 2022); Standard BioTools Inc. (Director · Since at least Apr 4, 2022); EQRx Inc (Director · Sep 30, 2022 – Sep 30, 2022 · Past); Tenaya Therapeutics, Inc. (Director · Jun 10, 2022 – Nov 17, 2022 · Past); Century Therapeutics, Inc. (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Absci Corporation (Director · Jun 8, 2022 – Jun 8, 2022 · Past) | Director · Mar 20, 2024 – May 13, 2025 · Past |
| Charles Newton Other companies: Keros Therapeutics, Inc. (Director · Since at least Feb 26, 2026); Novavax, Inc. (Director · Since at least Apr 25, 2025); Coherus Oncology, Inc. (Director · Since at least May 4, 2022); Lyell Immunopharma, Inc. (Chief Financial Officer · Since at least Jun 16, 2021) | Director · Mar 20, 2024 – May 13, 2025 · Past |
| Lin Wei Other companies: TCGX Acquisition Corp. (Director · Since at least Aug 4, 2026); Revolution Medicines, Inc. (Chief Medical Officer · Since at least Mar 21, 2024); Erasca, Inc. (Chief Medical Officer · Jul 15, 2021 – Feb 1, 2023 · Past) | Director · Mar 7, 2023 – May 13, 2025 · Past |
| Nick Leschly Other companies: Bluebird bio Inc (Director · Since at least Oct 2, 2020); Synlogic Inc (Director · Jun 10, 2021 – Jun 22, 2023 · Past) | Director · Oct 18, 2021 – May 13, 2025 · Past |
| Sarah JS Glickman Other companies: Criteo SA (Chief Financial Officer · Since at least May 23, 2025); AptarGroup, Inc. (Director · Since at least May 7, 2025) | Director · May 13, 2025 – May 13, 2025 · Past |
| Ramy Ibrahim Other companies: Surface Oncology Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past) | Director · Jun 8, 2022 – Jun 13, 2023 · Past |
| William R Sellers Other companies: Bluebird bio Inc (Director · Sep 25, 2019 – Nov 11, 2021 · Past) | Director · Oct 18, 2021 – Nov 11, 2021 · Past |
| Jessica Snow | Chief Operating Officer · May 13, 2025 – May 13, 2025 · Past |
| Nicola Heffron | Chief Operating Officer · Nov 4, 2021 – Feb 7, 2023 · Past |
| Victoria Eatwell | Chief Financial Officer · Apr 1, 2024 – May 13, 2025 · Past |
Log in to ask 6ix AI your own questions about 2Seventy Bio Inc.